Charles D. Nichols

6.8k total citations · 2 hit papers
85 papers, 4.9k citations indexed

About

Charles D. Nichols is a scholar working on Cellular and Molecular Neuroscience, Clinical Psychology and Molecular Biology. According to data from OpenAlex, Charles D. Nichols has authored 85 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cellular and Molecular Neuroscience, 39 papers in Clinical Psychology and 24 papers in Molecular Biology. Recurrent topics in Charles D. Nichols's work include Psychedelics and Drug Studies (39 papers), Neurotransmitter Receptor Influence on Behavior (31 papers) and Chemical synthesis and alkaloids (18 papers). Charles D. Nichols is often cited by papers focused on Psychedelics and Drug Studies (39 papers), Neurotransmitter Receptor Influence on Behavior (31 papers) and Chemical synthesis and alkaloids (18 papers). Charles D. Nichols collaborates with scholars based in United States, Sweden and Denmark. Charles D. Nichols's co-authors include Udai Bhan Pandey, David E. Nichols, Jaime Becnel, Thomas W. Flanagan, David Martin, Bangning Yu, Elaine Sanders‐Bush, James J. Becnel, Oscar W. Johnson and Meghan Hibicke and has published in prestigious journals such as Chemical Reviews, PLoS ONE and Scientific Reports.

In The Last Decade

Charles D. Nichols

78 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human Disease Models in Drosophila melanogaster and the Role of the Fly in Therapeutic Drug Discovery

2011 787 citations Udai Bhan Pandey, Charles D. Nichols Pharmacological Reviews profile →
Serotonin Receptors

2008 675 citations David E. Nichols, Charles D. Nichols profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles D. Nichols United States	36	2.3k	1.6k	1.5k	949	467	85	4.9k
Michael J. Forster United States	46	1.5k 0.6×	517 0.3×	3.0k 1.9×	354 0.4×	219 0.5×	155	6.9k
Javier González‐Maeso United States	37	3.5k 1.5×	1.8k 1.1×	2.5k 1.6×	817 0.9×	717 1.5×	101	5.6k
Hyman B. Niznik Canada	47	7.3k 3.1×	336 0.2×	5.5k 3.6×	231 0.2×	280 0.6×	103	11.0k
Jianhong Luo China	43	2.8k 1.2×	311 0.2×	2.9k 1.9×	173 0.2×	161 0.3×	140	6.1k
Eric Grouzmann Switzerland	42	2.5k 1.0×	741 0.5×	1.5k 1.0×	193 0.2×	72 0.2×	168	5.5k
Gregory M. Miller United States	37	2.1k 0.9×	331 0.2×	2.0k 1.3×	168 0.2×	210 0.4×	97	4.8k
Mark S. Sonders United States	24	3.2k 1.4×	218 0.1×	2.5k 1.6×	174 0.2×	175 0.4×	32	5.3k
Josée E. Leysen Belgium	45	3.7k 1.6×	168 0.1×	3.4k 2.2×	416 0.4×	155 0.3×	127	6.4k
Barbara J. Caldarone United States	34	1.2k 0.5×	196 0.1×	1.9k 1.2×	247 0.3×	326 0.7×	67	4.0k
Paul R. Albert Canada	51	4.5k 1.9×	377 0.2×	5.0k 3.2×	139 0.1×	784 1.7×	136	8.9k

Countries citing papers authored by Charles D. Nichols

Since Specialization

Citations

This map shows the geographic impact of Charles D. Nichols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles D. Nichols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles D. Nichols more than expected).

Fields of papers citing papers by Charles D. Nichols

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles D. Nichols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles D. Nichols. The network helps show where Charles D. Nichols may publish in the future.

Co-authorship network of co-authors of Charles D. Nichols

This figure shows the co-authorship network connecting the top 25 collaborators of Charles D. Nichols. A scholar is included among the top collaborators of Charles D. Nichols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles D. Nichols. Charles D. Nichols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cummins, Benjamin, et al.. (2025). 5-HT2A receptors: Pharmacology and functional selectivity. Pharmacological Reviews. 77(4). 100059–100059. 2 indexed citations

Nichols, Charles D. & Timothy P. Foster. (2025). Serotonin, immune function, and psychedelics as potent anti-inflammatories. International review of neurobiology. 181. 45–76. 1 indexed citations

Nichols, David E. & Charles D. Nichols. (2025). History of psychedelic drug science and molecular pharmacology. International review of neurobiology. 181. 3–43.

Hibicke, Meghan, et al.. (2024). Preadministration of Lorazepam Reduces Efficacy and Longevity of Antidepressant-Like Effect from a Psychedelic. PubMed. 2(1). 10–14. 1 indexed citations

Hibicke, Meghan, Hannah M. Kramer, & Charles D. Nichols. (2023). A Single Administration of Psilocybin Persistently Rescues Cognitive Deficits Caused by Adolescent Chronic Restraint Stress Without Long-Term Changes in Synaptic Protein Gene Expression in a Rat Experimental System with Translational Relevance to Depression. PubMed. 1(1). 54–67. 16 indexed citations

Aday, Jacob S., Brian S. Barnett, Dan Grossman, et al.. (2023). Psychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry. PubMed. 1(3). 150–165. 28 indexed citations

Albrechet‐Souza, Lucas, Rajani Maiya, Aspasia Destouni, et al.. (2023). Conditioned place avoidance is associated with a distinct hippocampal phenotype, partly preserved pattern separation, and reduced reactive oxygen species production after stress. Genes Brain & Behavior. 22(2). e12840–e12840. 4 indexed citations

Wulff, Andreas B., Charles D. Nichols, & Scott M. Thompson. (2023). Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders. Neuropharmacology. 231. 109504–109504. 19 indexed citations

Hendricks, Peter S., Charles D. Nichols, Kathryn A. Cunningham, et al.. (2022). Past, Present, and Future of Psychedelics: A Psychedelic Medicine Roundtable Discussion. PubMed. 1(1). 2–11. 1 indexed citations

10.

Liu, Howe, et al.. (2022). Effects of Tai Chi Practice on Brain as Assessed with Neuroimaging Techniques – A Scoping Review. 6(5). 1 indexed citations

11.

Nichols, Charles D.. (2022). Psychedelics as potent anti-inflammatory therapeutics. Neuropharmacology. 219. 109232–109232. 16 indexed citations

12.

Henningfield, Jack E., Marion A. Coe, Roland R. Griffiths, et al.. (2022). Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling. Neuropharmacology. 218. 109220–109220. 25 indexed citations

13.

Flanagan, Thomas W. & Charles D. Nichols. (2018). Psychedelics as anti-inflammatory agents. International Review of Psychiatry. 30(4). 363–375. 167 indexed citations

14.

Martin, David & Charles D. Nichols. (2017). The Effects of Hallucinogens on Gene Expression. Current topics in behavioral neurosciences. 36. 137–158. 41 indexed citations

15.

Martin, David & Charles D. Nichols. (2016). Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain. EBioMedicine. 11. 262–277. 66 indexed citations

16.

Martin, David, Danuta Marona‐Lewicka, David E. Nichols, & Charles D. Nichols. (2014). Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia. Neuropharmacology. 83. 1–8. 45 indexed citations

17.

Nichols, Charles D., Jaime Becnel, & Udai Bhan Pandey. (2012). Methods to Assay <em>Drosophila</em> Behavior. Journal of Visualized Experiments. 12 indexed citations

18.

Johnson, Oscar W., James J. Becnel, & Charles D. Nichols. (2011). Serotonin receptor activity is necessary for olfactory learning and memory in Drosophila melanogaster. Neuroscience. 192. 372–381. 54 indexed citations

19.

Becnel, Jaime, et al.. (2011). The Serotonin 5-HT7Dro Receptor Is Expressed in the Brain of Drosophila, and Is Essential for Normal Courtship and Mating. PLoS ONE. 6(6). e20800–e20800. 88 indexed citations

20.

Nichols, Charles D., et al.. (2003). Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration. Molecular Brain Research. 111(1-2). 182–188. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact